Intra-ethnic and geographic disparities in stage at diagnosis for non-small cell lung cancer
JNCI: Journal of the National Cancer Institute · 2024
DOI: 10.1093/jnci/djae199 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Qinran Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance & Health Equity Science Department, American Cancer Society, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Bankhead Coley Research.
Abstract (Originalsprache)
Background
Despite the importance of early detection for lung cancer outcomes, staging disparities among the growing US Hispanic population remain underexplored. This population-based study aimed to identify racial/ethnic disparities among non-Hispanic White, non-Hispanic Black, and Hispanic (including specific subgroups) patients in stage at diagnosis for potentially curable non-small cell lung cancer (NSCLC).
Methods
Incident NSCLC cases (2005-2018) were extracted from the Florida cancer registry. Stage was categorized as early (localized/regional) or advanced (distant). Multivariable logistic regression assessed the association between race/ethnicity and stage at diagnosis, adjusting for socioeconomic status, smoking, and clinical factors.
Results
Among 157 034 NSCLC patients, 47.8% were diagnosed at an advanced stage. Multivariable models showed higher odds of advanced-stage diagnosis for non-Hispanic Blacks (adjusted odds ratio [ORadj] = 1.22, 95% confidence interval [CI] = 1.17 to 1.26) and Hispanics (ORadj = 1.03, 95% CI = 1.00 to 1.08) compared with non-Hispanic Whites. Regional differences were stark for Hispanics compared with non-Hispanic Whites: ORadj = 0.96 (95% CI = 0.91 to 1.01) in South Florida vs 1.12 (95% CI = 1.05 to 1.19) in the rest of Florida. In South Florida, Central Americans (ORadj = 1.49, 95% CI = 1.20 to 1.85) were the only Hispanic group showing a staging disadvantage compared with non-Hispanic Whites.
Conclusion
Pronounced disparities in NSCLC staging among non-Hispanic Black and Hispanic populations, with notable regional variations within Florida’s Hispanic communities, indicate that targeted interventions could significantly enhance early detection. The relative advantage observed in nearly all minority groups in multicultural South Florida compared with the rest of Florida underscores the need for future research exploring how specific Hispanic and multiracial sociocultural contexts can positively influence the landscape of cancer early detection across the United States.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Surveillance & Health Equity Science Department, American Cancer Society, Atlanta, GA, USA.
- Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL, USA.
- Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
- Departments of Psychology and Medicine, University of Miami, Miami, FL, USA.
ORCID-Profile: Qinran Liu, Tulay Koru-Sengul, Estelamari Rodriguez, Gilberto Lopes, Farhad Islami
Förderung
- Bankhead Coley Research
Zitieren
APA
Liu, Q., Medina, H. N., Koru-Sengul, T., Rodriguez, E., Lopes, G., Penedo, F. J., Islami, F., & Pinheiro, P. S. (2024). Intra-ethnic and geographic disparities in stage at diagnosis for non-small cell lung cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae199
Vancouver
Liu Q, Medina HN, Koru-Sengul T, Rodriguez E, Lopes G, Penedo FJ, et al. Intra-ethnic and geographic disparities in stage at diagnosis for non-small cell lung cancer. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae199
BibTeX
@article{Liu2024,
author = {Liu, Qinran and Medina, Heidy N and Koru-Sengul, Tulay and Rodriguez, Estelamari and Lopes, Gilberto and Penedo, Frank J and Islami, Farhad and Pinheiro, Paulo S},
title = {Intra-ethnic and geographic disparities in stage at diagnosis for non-small cell lung cancer},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
doi = {10.1093/jnci/djae199}
}
EUVIMED